Bradley Foster & Sargent’s Axogen AXGN Stock Holding History

Bradley Foster & Sargent’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	24,577 +598	+2%	+$24.1K	0.02%	290
2026 Q1	$794K	Sell	23,979 -38,207	-61%	-$1.24M	0.01%	321
2025 Q4	$2.04M	Hold	62,186	–	–	0.03%	219
2025 Q3	$1.11M	Hold	62,186	–	–	0.02%	278
2025 Q2	$675K	Sell	62,186 -2,219	-3%	-$29.1K	0.01%	338
2025 Q1	$1.19M	Sell	64,405 -19,748	-23%	-$356K	0.02%	259
2024 Q4	$1.39M	Buy	84,153 +2,989	+4%	+$42.3K	0.02%	244
2024 Q3	$1.14M	Buy	+81,164	New	+$898K	0.02%	266
2018 Q4	–	Sell	-12,175	Closed	-$449K	–	340
2018 Q3	$449K	Buy	12,175 +3,675	+43%	+$160K	0.02%	293
2018 Q2	$427K	Sell	8,500 -23,780	-74%	-$1.05M	0.02%	295
2018 Q1	$1.18M	Sell	32,280 -11,000	-25%	-$337K	0.04%	206
2017 Q4	$1.23M	Sell	43,280 -35,625	-45%	-$841K	0.04%	200
2017 Q3	$1.53M	Hold	78,905	–	–	0.06%	181
2017 Q2	$1.32M	Buy	78,905 +66,510	+537%	+$897K	0.05%	184
2017 Q1	$130K	Buy	+12,395	New	+$126K	0.01%	334

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bradley Foster & Sargent's AXGN Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Axogen (AXGN) stake by 2.5% in Q2 2026, buying an estimated $24.1K and bringing the position to 24,577 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #290.

Bradley Foster & Sargent first reported a position in AXGN in Q1 2017 and has held it in 15 quarters since. The position peaked at $2.04M in Q4 2025. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Bradley Foster & Sargent held 24,577 shares of Axogen worth $1.14M as of Q2 2026.
Bradley Foster & Sargent bought 598 Axogen shares in Q2 2026, an estimated $24.1K.
Axogen made up 0.02% of Bradley Foster & Sargent's portfolio in Q2 2026, its #290 holding.
Bradley Foster & Sargent first reported a position in Axogen in Q1 2017 and has held it in 15 quarters since.
Bradley Foster & Sargent's Axogen position peaked at $2.04M in Q4 2025.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.